Agilent Technologies, Inc. (NYSE:A) Stock Holdings Lessened by MML Investors Services LLC

MML Investors Services LLC trimmed its holdings in Agilent Technologies, Inc. (NYSE:A - Free Report) by 11.7% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 38,132 shares of the medical research company's stock after selling 5,073 shares during the quarter. MML Investors Services LLC's holdings in Agilent Technologies were worth $5,123,000 at the end of the most recent quarter.

A number of other large investors have also recently bought and sold shares of the business. CKW Financial Group raised its position in Agilent Technologies by 114.9% during the 4th quarter. CKW Financial Group now owns 187 shares of the medical research company's stock worth $25,000 after buying an additional 100 shares during the last quarter. Global X Japan Co. Ltd. increased its stake in shares of Agilent Technologies by 161.1% during the fourth quarter. Global X Japan Co. Ltd. now owns 188 shares of the medical research company's stock worth $25,000 after acquiring an additional 116 shares during the period. Redwood Park Advisors LLC purchased a new position in Agilent Technologies during the fourth quarter worth about $27,000. Lee Danner & Bass Inc. acquired a new stake in Agilent Technologies in the fourth quarter valued at about $29,000. Finally, Hanson & Doremus Investment Management boosted its holdings in Agilent Technologies by 66.5% in the 4th quarter. Hanson & Doremus Investment Management now owns 263 shares of the medical research company's stock valued at $35,000 after purchasing an additional 105 shares in the last quarter. Institutional investors and hedge funds own 87.42% of the company's stock.

Insider Activity

In other Agilent Technologies news, VP Rodney Gonsalves sold 1,908 shares of the firm's stock in a transaction on Monday, March 17th. The shares were sold at an average price of $121.98, for a total transaction of $232,737.84. Following the completion of the transaction, the vice president now directly owns 21,786 shares of the company's stock, valued at $2,657,456.28. This trade represents a 8.05 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Daniel K. Podolsky sold 1,819 shares of the company's stock in a transaction dated Monday, March 31st. The shares were sold at an average price of $116.46, for a total transaction of $211,840.74. Following the completion of the sale, the director now owns 35,737 shares in the company, valued at approximately $4,161,931.02. This trade represents a 4.84 % decrease in their position. The disclosure for this sale can be found here. Insiders own 0.26% of the company's stock.

Analyst Ratings Changes

A number of equities analysts have recently issued reports on the company. Barclays cut their target price on Agilent Technologies from $138.00 to $115.00 and set an "equal weight" rating for the company in a research note on Thursday, April 10th. TD Cowen increased their price objective on Agilent Technologies to $135.00 and gave the stock a "buy" rating in a research report on Thursday, April 10th. Wells Fargo & Company decreased their target price on shares of Agilent Technologies from $155.00 to $135.00 and set an "overweight" rating on the stock in a research report on Thursday, April 17th. Jefferies Financial Group cut their price target on shares of Agilent Technologies from $135.00 to $116.00 and set a "hold" rating for the company in a report on Monday, April 21st. Finally, Robert W. Baird decreased their price objective on shares of Agilent Technologies from $161.00 to $159.00 and set an "outperform" rating on the stock in a report on Thursday, February 27th. Seven analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus target price of $143.00.

Agilent Technologies Trading Up 0.6 %

NYSE:A traded up $0.59 during trading hours on Tuesday, reaching $107.46. 1,201,767 shares of the company were exchanged, compared to its average volume of 1,871,450. The firm has a market cap of $30.64 billion, a price-to-earnings ratio of 24.70, a PEG ratio of 3.00 and a beta of 1.19. The stock has a 50 day simple moving average of $115.80 and a 200 day simple moving average of $130.66. Agilent Technologies, Inc. has a 52-week low of $96.43 and a 52-week high of $155.35. The company has a debt-to-equity ratio of 0.56, a current ratio of 2.20 and a quick ratio of 1.66.

Agilent Technologies (NYSE:A - Get Free Report) last posted its quarterly earnings results on Wednesday, February 26th. The medical research company reported $1.31 EPS for the quarter, beating the consensus estimate of $1.27 by $0.04. The firm had revenue of $1.68 billion for the quarter, compared to analyst estimates of $1.67 billion. Agilent Technologies had a net margin of 19.27% and a return on equity of 25.56%. As a group, analysts predict that Agilent Technologies, Inc. will post 5.54 EPS for the current year.

Agilent Technologies Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, April 23rd. Shareholders of record on Tuesday, April 1st were issued a $0.248 dividend. The ex-dividend date of this dividend was Tuesday, April 1st. This represents a $0.99 dividend on an annualized basis and a yield of 0.92%. Agilent Technologies's dividend payout ratio is currently 22.76%.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.